Cinnamaldehyde, a natural TLR4 inhibitor, alleviates hypoxia-induced PAH in vivo by suppressing the TLR4/NF-κB/HIF-1α pathway, reducing right ventricular hypertrophy and collagen deposition [52,89]. The gene discussed is TLR4; the disease is pulmonary arterial hypertension.